Figure 3From: Characterization of Bridging Integrator 1 (BIN1) as a Potential Tumor Suppressor and Prognostic Marker in Hepatocellular CarcinomaCorrelation of overall survival with the expression of BIN1 in 117 HCC patients. On the basis of the results of immunohistochemical staining, log-rank test revealed that HCC patients with low BIN1 expression showed significantly poorer prognoses than patients with high BIN1 expression (P= 0.003, Kaplan-Meier method). Experiments were performed two times. Cum, cumulative. ......, low BIN1 group; —, high BIN1 group,Back to article page